← Leaderboards
Huiyan Zeng
Beth Israel Deaconess Medical Center
$2,837,132
Attributed
$2,837,132
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $352.8K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,837,132 · 5
By mechanism
R01$1,711,474 · 1
K01$715,095 · 1
R03$348,000 · 2
F32$62,563 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Henry N Higgs$16,490,245
- Dong-Er Zhang$30,254,830
- Vassiliki A Boussiotis$19,288,605
- Benjamin E Turk$10,825,159
- Lewis C Cantley$35,988,650
Others in their field
Top investigators on “Vascular Endothelial Growth Factors”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Michael Simons · Yale University$37,207,792
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Shahin Rafii · Weill Medical College Of Cornell Univ$24,406,332
- Rakesh K. Jain · Massachusetts General Hospital$23,479,897
- Aleksander S. Popel · Johns Hopkins University$19,039,579
Research focus
Vascular Endothelial Growth FactorsAngiogenesisCell ProliferationTumorAngiogenic FactorEndotheliumTranscription FactorIn VitroEndothelial CellsPlayTransgenic MiceMatrigelTumor AngiogenesisPermeabilitySolid NeoplasmAdverse EffectsColonTumor GrowthMolecularNr4a1 GenePathologic NeovascularizationIn VivoOverexpressionDefect
Grant awards (16)
Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis$87,000
R03 · FY2016 · CA · contact PI
Targeting orphan nuclear receptor TR3/Nur77 for tumor angiogenesis$87,000
R03 · FY2016 · CA · contact PI
Targeting orphan nuclear receptor TR3/Nur77 for tumor angiogenesis$87,000
R03 · FY2015 · CA · contact PI
Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis$87,000
R03 · FY2015 · CA · contact PI
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm$321,638
R01 · FY2013 · CA · contact PI
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm$342,168
R01 · FY2012 · CA · contact PI
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm$342,168
R01 · FY2011 · CA · contact PI
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm$352,750
R01 · FY2010 · CA · contact PI
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm$352,750
R01 · FY2009 · CA · contact PI
Expression and Function of TR3/nur77 in angiogenesis$155,979
K01 · FY2007 · CA · contact PI
Expression and Function of TR3/nur77 in angiogenesis$155,979
K01 · FY2006 · CA · contact PI
Expression and Function of TR3/nur77 in angiogenesis$134,379
K01 · FY2005 · CA
Expression and Function of TR3/nur77 in angiogenesis$134,379
K01 · FY2004 · CA
Expression and Function of TR3/nur77 in angiogenesis$134,379
K01 · FY2003 · CA
FUNCTIONAL DISSECTIONS OF VEGF RECEPTORS IN ENDOTHELIUM$30,147
F32 · FY2001 · CA
FUNCTIONAL DISSECTIONS OF VEGF RECEPTORS IN ENDOTHELIUM$32,416
F32 · FY2000 · CA